147 related articles for article (PubMed ID: 17420720)
1. Brca1 heterozygous mice have shortened life span and are prone to ovarian tumorigenesis with haploinsufficiency upon ionizing irradiation.
Jeng YM; Cai-Ng S; Li A; Furuta S; Chew H; Chen PL; Lee EY; Lee WH
Oncogene; 2007 Sep; 26(42):6160-6. PubMed ID: 17420720
[TBL] [Abstract][Full Text] [Related]
2. Mammary tumor formation in p53- and BRCA1-deficient mice.
Cressman VL; Backlund DC; Hicks EM; Gowen LC; Godfrey V; Koller BH
Cell Growth Differ; 1999 Jan; 10(1):1-10. PubMed ID: 9950212
[TBL] [Abstract][Full Text] [Related]
3. Nbn heterozygosity renders mice susceptible to tumor formation and ionizing radiation-induced tumorigenesis.
Dumon-Jones V; Frappart PO; Tong WM; Sajithlal G; Hulla W; Schmid G; Herceg Z; Digweed M; Wang ZQ
Cancer Res; 2003 Nov; 63(21):7263-9. PubMed ID: 14612522
[TBL] [Abstract][Full Text] [Related]
4. Impact of ionizing radiation and genetic background on mammary tumorigenesis in p53-deficient mice.
Backlund MG; Trasti SL; Backlund DC; Cressman VL; Godfrey V; Koller BH
Cancer Res; 2001 Sep; 61(17):6577-82. PubMed ID: 11522657
[TBL] [Abstract][Full Text] [Related]
5. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.
Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T
Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760
[TBL] [Abstract][Full Text] [Related]
6. Genomic alterations in histopathologically normal breast tissue from BRCA1 mutation carriers may be caused by BRCA1 haploinsufficiency.
Rennstam K; Ringberg A; Cunliffe HE; Olsson H; Landberg G; Hedenfalk I
Genes Chromosomes Cancer; 2010 Jan; 49(1):78-90. PubMed ID: 19839046
[TBL] [Abstract][Full Text] [Related]
7. A targeted disruption of the murine Brca1 gene causes gamma-irradiation hypersensitivity and genetic instability.
Shen SX; Weaver Z; Xu X; Li C; Weinstein M; Chen L; Guan XY; Ried T; Deng CX
Oncogene; 1998 Dec; 17(24):3115-24. PubMed ID: 9872327
[TBL] [Abstract][Full Text] [Related]
8. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.
Xu X; Qiao W; Linke SP; Cao L; Li WM; Furth PA; Harris CC; Deng CX
Nat Genet; 2001 Jul; 28(3):266-71. PubMed ID: 11431698
[TBL] [Abstract][Full Text] [Related]
9. [A paradox and three egnimas about the role of BRCA1 in breast and ovarian cancers].
Feunteun J
J Soc Biol; 2004; 198(2):123-6. PubMed ID: 15368961
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation.
DelloRusso C; Welcsh PL; Wang W; Garcia RL; King MC; Swisher EM
Mol Cancer Res; 2007 Jan; 5(1):35-45. PubMed ID: 17259345
[TBL] [Abstract][Full Text] [Related]
11. Dominant-negative activity of a Brca1 truncation mutant: effects on proliferation, tumorigenicity in vivo, and chemosensitivity in a mouse ovarian cancer cell line.
Sylvain V; Lafarge S; Bignon YJ
Int J Oncol; 2002 Apr; 20(4):845-53. PubMed ID: 11894135
[TBL] [Abstract][Full Text] [Related]
12. Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis.
King TA; Li W; Brogi E; Yee CJ; Gemignani ML; Olvera N; Levine DA; Norton L; Robson ME; Offit K; Borgen PI; Boyd J
Ann Surg Oncol; 2007 Sep; 14(9):2510-8. PubMed ID: 17597348
[TBL] [Abstract][Full Text] [Related]
13. Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation.
Deng CX; Scott F
Oncogene; 2000 Feb; 19(8):1059-64. PubMed ID: 10713690
[TBL] [Abstract][Full Text] [Related]
14. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
15. BRCA1 in breast and ovarian cancer predisposition.
Billack B; Monteiro AN
Cancer Lett; 2005 Sep; 227(1):1-7. PubMed ID: 16051027
[TBL] [Abstract][Full Text] [Related]
16. Normal lymphocyte development and thymic lymphoma formation in Brca1 exon-11-deficient mice.
Bachelier R; Xu X; Wang X; Li W; Naramura M; Gu H; Deng CX
Oncogene; 2003 Jan; 22(4):528-37. PubMed ID: 12555066
[TBL] [Abstract][Full Text] [Related]
17. Early radiation exposures and BRCA1-associated breast cancer in young women from Poland.
Gronwald J; Pijpe A; Byrski T; Huzarski T; Stawicka M; Cybulski C; van Leeuwen F; Lubiński J; Narod SA
Breast Cancer Res Treat; 2008 Dec; 112(3):581-4. PubMed ID: 18205043
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic and cellular events during radiation-induced thymic lymphomagenesis in the p53 heterozygous (+/-) B10 mouse.
Tanaka K; Watanabe K; Mori M; Kamisaku H; Tsuji H; Hirabayashi Y; Inoue T; Yoshida K; Aizawa S
Int J Radiat Biol; 2002 Mar; 78(3):165-72. PubMed ID: 11869471
[TBL] [Abstract][Full Text] [Related]
19. Tumor formation in mice with conditional inactivation of Brca1 in epithelial tissues.
Berton TR; Matsumoto T; Page A; Conti CJ; Deng CX; Jorcano JL; Johnson DG
Oncogene; 2003 Aug; 22(35):5415-26. PubMed ID: 12934101
[TBL] [Abstract][Full Text] [Related]
20. The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain.
Milne RL; Osorio A; Cajal TR; Vega A; Llort G; de la Hoya M; Díez O; Alonso MC; Lazaro C; Blanco I; Sánchez-de-Abajo A; Caldés T; Blanco A; Graña B; Durán M; Velasco E; Chirivella I; Cardeñosa EE; Tejada MI; Beristain E; Miramar MD; Calvo MT; Martínez E; Guillén C; Salazar R; San Román C; Antoniou AC; Urioste M; Benítez J
Clin Cancer Res; 2008 May; 14(9):2861-9. PubMed ID: 18451254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
